Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
UNLIMITED Watchlists, Portfolios, Screeners, and other Barchart tools with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Hims & Hers Health Inc (HIMS)

Hims & Hers Health Inc (HIMS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 3,309,675
  • Shares Outstanding, K 227,939
  • Annual Sales, $ 1,477 M
  • Annual Income, $ 126,040 K
  • EBIT $ 115 M
  • EBITDA $ 128 M
  • 60-Month Beta 2.43
  • Price/Sales 1.41
  • Price/Cash Flow 18.64
  • Price/Book 6.55

Options Overview Details

View History
  • Implied Volatility 91.85% (+0.81%)
  • Historical Volatility 71.62%
  • IV Percentile 51%
  • IV Rank 42.73%
  • IV High 135.37% on 04/08/25
  • IV Low 59.38% on 12/31/25
  • Expected Move (DTE 6) 1.06 (7.32%)
  • Put/Call Vol Ratio 0.49
  • Today's Volume 134,263
  • Volume Avg (30-Day) 173,467
  • Put/Call OI Ratio 0.56
  • Today's Open Interest 1,142,331
  • Open Int (30-Day) 972,289
  • Expected Range 13.46 to 15.58

Analyst Rating / Earnings Estimates

Current Rating
See More
Hold
Based on 15 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/26
See More
  • Average Estimate 0.02
  • Number of Estimates 4
  • High Estimate 0.04
  • Low Estimate -0.02
  • Prior Year 0.20
  • Growth Rate Est. (year over year) -90.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
13.74 +5.68%
on 02/24/26
30.70 -52.70%
on 01/29/26
-15.16 (-51.08%)
since 01/27/26
3-Month
13.74 +5.68%
on 02/24/26
40.99 -64.58%
on 12/05/25
-23.88 (-62.19%)
since 11/26/25
52-Week
13.74 +5.68%
on 02/24/26
70.43 -79.38%
on 07/31/25
-26.82 (-64.88%)
since 02/27/25

Most Recent Stories

More News
PacBio, Myriad Genetics, LeMaitre, Hims & Hers Health, and GoodRx Shares Are Falling, What You Need To Know

PacBio, Myriad Genetics, LeMaitre, Hims & Hers Health, and GoodRx Shares Are Falling, What You Need To Know

GDRX : 1.8700 (-6.03%)
PACB : 1.6800 (-5.62%)
HIMS : 14.52 (-6.92%)
MYGN : 4.61 (-5.14%)
LMAT : 108.18 (-4.85%)
Law Offices of Howard G. Smith Announces Investigation of Hims & Hers Health, Inc. (HIMS) on Behalf of Investors

Law Offices of Howard G. Smith announces it is investigating potential claims against the board of directors of Hims & Hers Health, Inc. (“Hims” or the “Company”) (NYSE: HIMS ) concerning...

HIMS : 14.52 (-6.92%)
The Law Offices of Frank R. Cruz Announces Investigation of Hims & Hers Health, Inc. (HIMS) on Behalf of Investors

The Law Offices of Frank R. Cruz is investigating potential claims against the board of directors of Hims & Hers Health, Inc. (“Hims” or the “Company”) (NYSE: HIMS ) concerning...

HIMS : 14.52 (-6.92%)
Stocks Rebound as Software Stocks Recover

The S&P 500 Index ($SPX ) (SPY ) today is up +0.17%, the Dow Jones Industrial Average ($DOWI ) (DIA ) is up +0.64%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +0.47%. March E-mini S&P futures (ESH26...

INTU : 409.03 (+3.70%)
HSIC : 82.39 (+1.13%)
HIMS : 14.52 (-6.92%)
DDOG : 111.96 (-3.86%)
EXPD : 145.03 (+0.21%)
PAY : 24.47 (-1.45%)
$IUXX : 24,960.04 (-0.30%)
BWXT : 205.98 (-0.61%)
ZNM26 : 113-260s (+0.40%)
ESH26 : 6,889.00s (-0.45%)
QCOM : 142.36 (-2.22%)
KEYS : 307.33 (+0.42%)
Stock Index Futures Mixed With Focus on Trump’s SOTU Address and U.S. Economic Data

March S&P 500 E-Mini futures (ESH26) are down -0.04%, and March Nasdaq 100 E-Mini futures (NQH26) are up +0.21% this morning as sentiment remains cautious following yesterday’s selloff on Wall Street...

PYPL : 46.21 (+1.49%)
CEG : 329.88 (+1.95%)
JPM : 300.30 (-1.90%)
HIMS : 14.52 (-6.92%)
DDOG : 111.96 (-3.86%)
HPQ : 18.99 (+0.96%)
ESH26 : 6,889.00s (-0.45%)
WDAY : 133.76 (-3.85%)
IBM : 240.21 (-0.74%)
QCOM : 142.36 (-2.22%)
KDP : 30.28 (-0.16%)
KEYS : 307.33 (+0.42%)
Hims & Hers Health’s (NYSE:HIMS) Q4 CY2025 Earnings Results: Revenue In Line With Expectations

Hims & Hers Health’s (NYSE:HIMS) Q4 CY2025 Earnings Results: Revenue In Line With Expectations

HIMS : 14.52 (-6.92%)
Hims & Hers Health, Inc. Reports Fourth Quarter and Full Year 2025 Financial Results

Revenue of approximately $2.35 billion, up 59% year-over-year in 2025 Net income of $128 million; Adjusted EBITDA of $318 million in 2025 ...

HIMS : 14.52 (-6.92%)
What To Expect From Hims & Hers Health’s (HIMS) Q4 Earnings

What To Expect From Hims & Hers Health’s (HIMS) Q4 Earnings

HIMS : 14.52 (-6.92%)
Hims & Hers in Free Fall: Why Analysts See Nearly 150% Upside

HIMS is down 48% in the past month following a Novo Nordisk lawsuit. But, analysts expect record revenue when the company reports earnings this month.

HIMS : 14.52 (-6.92%)
NVO : 37.45 (-0.45%)
Hims & Hers Announces Agreement to Acquire Eucalyptus, Accelerating Its Vision to Become the Leading Global Consumer Health Platform

Eucalyptus is a consumer healthcare leader in Australia, the UK and Germany, with expanding new operations in Japan and Canada.

HIMS : 14.52 (-6.92%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Sell with a Strongest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

Relative Strength is below 20%. The market is in extreme oversold territory. Beware of a trend reversal.

See More Share

Business Summary

Hims & Hers Health Inc. is a multi-specialty telehealth platform that connects consumers to licensed healthcare professionals, enabling medical care for numerous conditions related to mental health, sexual health, dermatology, primary care and more. Hims & Hers Health Inc., formerly known as Oaktree...

See More

Key Turning Points

3rd Resistance Point 15.86
2nd Resistance Point 15.58
1st Resistance Point 15.05
Last Price 14.52
1st Support Level 14.24
2nd Support Level 13.95
3rd Support Level 13.42

See More

52-Week High 70.43
Fibonacci 61.8% 48.77
Fibonacci 50% 42.08
Fibonacci 38.2% 35.40
Last Price 14.52
52-Week Low 13.74

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar